Gold conjugated nanobodies in a signal-enhanced lateral flow test strip for rapid detection of SARS-CoV-2 S1 antigen in saliva samples

Bibliographic Information
Authors: Maher S.; Kamel M.; Demerdash Z.; El Baz H.; Sayyouh O.; Saad A.; Ali N.; Salah F.; Atta S.
Journal: Scientific Reports
Publisher: Nature Research
Publication Date: 30 June 2023
Volume / Issue: Volume 13 / Issue 1
Article No.: 10643
ISSN: 20452322
DOI: 10.1038/s41598-023-37347-y
Scopus: View on Scopus
PubMed: 37391465
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Maher S., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Kamel M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Demerdash Z., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; El Baz H., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Sayyouh O., Infection Control and Clinical Microbiology, Theodor Bilharz Research Institute, Giza, Egypt; Saad A., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Ali N., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Salah F., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Atta S., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Despite the transfer of COVID-19 from the pandemic to control, we are still in a state of uncertainty about long-term success. Therefore, there is a great need for rapid and sensitive diagnostics to sustain the control status. After several optimization trials, we developed lateral flow test (LFT) strips for rapid detection of SARS-CoV-2 spike 1 (S1) antigen in saliva samples. For signal enhancement of our developed strips, we applied dual gold conjugates. Gold-labeled anti-S1 nanobodies (Nbs) were employed as S1 detector conjugate, while gold-labeled angiotensin-converting enzyme 2 (ACE2) was used as S1 capturing conjugate. In a parallel strip design, we used an anti-S1 monoclonal antibody (mAb) as an antigen detector instead of anti-S1 Nbs. Saliva samples were collected from 320 symptomatic subjects (180 RT-PCR confirmed positive cases and 140 confirmed negative cases) and were tested with the developed strips. In early detection for positive samples with cycle threshold (Ct ≤ 30), Nbs-based LFT strips showed higher sensitivity (97.14%) and specificity (98.57%) than mAb-based strips which gave 90.04% sensitivity and 97.86% specificity. Moreover, the limit of detection (LoD) for virus particles was lower for Nbs-based LFT (0.4 × 104 copies/ml) than for the mAb-based test (1.6 × 104 copies/ml). Our results are in favor of the use of dual gold Nbs and ACE2 conjugates in LFT strips. These signal-enhanced strips offer a sensitive diagnostic tool for rapid screening of SARS-CoV-2 S1 antigen in the easily collected saliva samples. © 2023, The Author(s).
Keywords
Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal; COVID-19; Humans; Saliva; SARS-CoV-2; Single-Domain Antibodies; angiotensin converting enzyme 2; monoclonal antibody; nanobody; sarcoma-associated antigen S1; coronavirus disease 2019; human; Severe acute respiratory syndrome coronavirus 2
Citation Information
Scopus Citations: 20
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
